SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-19-001758
Filing Date
2019-03-15
Accepted
2019-03-15 13:09:15
Documents
59
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_031419p.htm 10-K/A 298311
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7768
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7663
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3046
5 EXHIBIT 32.2 exh_322.htm EX-32.2 2985
  Complete submission text file 0001171843-19-001758.txt   3151296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xbit-20181231.xml EX-101.INS 667861
7 XBRL SCHEMA FILE xbit-20181231.xsd EX-101.SCH 38833
8 XBRL CALCULATION FILE xbit-20181231_cal.xml EX-101.CAL 33612
9 XBRL DEFINITION FILE xbit-20181231_def.xml EX-101.DEF 260230
10 XBRL LABEL FILE xbit-20181231_lab.xml EX-101.LAB 236003
11 XBRL PRESENTATION FILE xbit-20181231_pre.xml EX-101.PRE 286753
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37347 | Film No.: 19684290
SIC: 2834 Pharmaceutical Preparations